U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07349589) titled 'Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers' on Jan. 07.
Brief Summary: This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5524 in healthy adult volunteers.
Study Start Date: Feb. 01
Study Type: INTERVENTIONAL
Condition:
Healthy Adult
Intervention:
DRUG: DW5524
DW5524
DRUG: DW5524-A
DW5524-A
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Daewon Pharmaceutical Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....